MITF and neoplasm: Finally, the clinical implications were investigated by comparing the expression profiles of SOX5, SOX10 and MITF to clinically relevant parameters (overall survival and tumor stage), leading to a biomarker regression model (of SOX5, SOX10 and MITF).